Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.09%30.93M | 3.17%33.7M | -18.17%21.71M | -14.20%128.62M | -11.03%41.34M | -24.11%28.1M | -3.57%32.67M | -18.48%26.53M | -5.89%149.91M | 3.35%46.46M |
| Cost of revenue | 8.35%30.5M | 2.87%27.7M | -2.94%22.75M | -15.55%113.63M | -17.94%34.41M | -2.95%28.15M | -7.18%26.93M | -20.53%23.44M | -4.27%134.55M | -2.16%41.94M |
| Gross profit | 989.80%436K | 4.57%6M | -133.73%-1.04M | -2.38%14.99M | 53.09%6.93M | -100.61%-49K | 17.93%5.74M | 1.31%3.09M | -18.04%15.36M | 115.94%4.52M |
| Operating expense | -22.14%1.48M | -47.70%4.03M | 64.11%3.38M | 1,206.03%14.73M | 86.46%3.14M | -58.03%1.9M | 133.75%7.7M | 160.81%2.06M | -77.72%1.13M | 165.53%1.68M |
| Selling and administrative expenses | -4.76%3.6M | -0.90%3.43M | 5.19%3.51M | 35.48%19.15M | 120.78%8.84M | 5.97%3.78M | -1.31%3.46M | -1.21%3.34M | -2.48%14.14M | -1.93%4M |
| -Selling and marketing expense | -4.49%1M | -11.74%827K | 8.46%885K | 4.83%4.15M | 3.14%1.35M | 9.40%1.05M | 8.95%937K | -1.57%816K | -8.30%3.95M | -9.17%1.31M |
| -General and administrative expense | -4.87%2.6M | 3.13%2.6M | 4.13%2.62M | 47.38%15.01M | 177.79%7.49M | 4.72%2.73M | -4.65%2.53M | -1.10%2.52M | -0.01%10.18M | 2.00%2.7M |
| Other operating expenses | ---- | -87.88%597K | ---- | -20.05%3.22M | ---- | ---- | 602.57%4.93M | ---- | -17.67%4.03M | 36.53%5.47M |
| Total other operating income | 12.76%2.12M | ---- | -90.19%125K | -55.16%7.64M | -26.85%5.7M | 18.08%1.88M | -25.05%685K | -81.27%1.27M | 18.92%17.04M | -26.91%7.79M |
| Operating profit | 46.51%-1.04M | 200.20%1.97M | -530.96%-4.43M | -98.17%261K | 33.31%3.79M | -155.54%-1.95M | -225.30%-1.97M | -84.05%1.03M | 4.05%14.23M | -39.12%2.84M |
| Net non-operating interest income (expenses) | -53.11%143K | -16.36%271K | -13.27%268K | 29.63%1.2M | -2.51%233K | 19.14%305K | 52.11%324K | 98.08%309K | 182.93%928K | 210.39%239K |
| Non-operating interest income | -8.24%345K | 0.99%407K | -8.39%382K | 18.79%1.57M | 9.09%372K | 4.44%376K | 16.14%403K | 100.48%417K | 157.31%1.32M | 135.17%341K |
| Non-operating interest expense | 184.51%202K | 72.15%136K | 5.56%114K | -6.89%365K | 36.27%139K | -31.73%71K | -41.04%79K | 107.69%108K | 111.89%392K | 50.00%102K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | -235.48%-294K | -250.23%-326K | 0 | 0 | 0 | -40.71%217K | -40.71%217K |
| Special income (charges) | 0 | 0 | 0 | -360.64%-245K | -432.33%-442K | 0 | 0 | 0 | 223.68%94K | 275.00%133K |
| Less:Write off | --0 | --0 | --0 | 360.64%245K | 432.33%442K | --0 | --0 | --0 | -223.68%-94K | -275.00%-133K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 45.28%-898K | 236.48%2.24M | -411.23%-4.16M | -94.02%925K | -5.19%3.25M | -143.64%-1.64M | -192.14%-1.64M | -79.75%1.34M | 8.22%15.47M | -31.86%3.43M |
| Income tax | -103.07%-19K | 154.44%239K | -98.70%7K | -108.31%-588K | -128.31%-1.04M | -43.47%619K | -171.50%-439K | -68.45%538K | 94.29%7.07M | 127.75%3.66M |
| Net income | 61.11%-879K | 266.42%2M | -621.93%-4.17M | -81.98%1.51M | 1,955.84%4.29M | -184.80%-2.26M | -203.00%-1.2M | -83.68%798K | -21.19%8.4M | -106.74%-231K |
| Net income continuous operations | 61.11%-879K | 266.42%2M | -621.93%-4.17M | -81.98%1.51M | 1,955.84%4.29M | -184.80%-2.26M | -203.00%-1.2M | -83.68%798K | -21.19%8.4M | -106.74%-231K |
| Noncontrolling interests | 87.50%-1K | -310.00%-41K | 83.33%-5K | 54.17%-77K | 44.83%-32K | 72.41%-8K | 70.59%-10K | 36.17%-30K | -100.00%-168K | -20.83%-58K |
| Net income attributable to the company | 61.01%-878K | 271.25%2.04M | -602.42%-4.16M | -81.43%1.59M | 2,596.53%4.32M | -183.59%-2.25M | -199.25%-1.19M | -83.23%828K | -20.25%8.56M | -104.98%-173K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 61.01%-878K | 271.25%2.04M | -602.42%-4.16M | -81.43%1.59M | 2,596.53%4.32M | -183.59%-2.25M | -199.25%-1.19M | -83.23%828K | -20.25%8.56M | -104.98%-173K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 99.61%-0.0038 | 269.23%0.0088 | -400.00%-0.018 | -87.93%0.007 | 2,757.14%0.0186 | -8,462.07%-0.97 | -200.00%-0.0052 | -200.00%-0.0036 | -19.44%0.058 | -103.40%-0.0007 |
| Diluted earnings per share | 99.61%-0.0038 | 269.23%0.0088 | -400.00%-0.018 | -87.93%0.007 | 2,757.14%0.0186 | -8,462.07%-0.97 | -200.00%-0.0052 | -200.00%-0.0036 | -19.44%0.058 | -104.67%-0.0007 |
| Dividend per share | 0 | -33.33%0.02 | 0 | 12.50%0.03 | 0 | 0 | 12.50%0.03 | 0 | 0.00%0.0267 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.